10/09/2024 | Press release | Distributed by Public on 10/09/2024 21:35
Contact:
Liver cancer is the fourth leading cause of cancer-related deaths in Hawaiʻi, disproportionately affecting Native Hawaiian, Filipino and Japanese men. As tumors spread to healthy parts of the liver, patients often experience rapid health decline, leading to liver failure and, tragically, death.
To raise awareness and provide support, the University of Hawaiʻi Cancer Center invites the community to the final event of its 2024 "Quest for a Cure" symposium series. This free event, dedicated to those impacted by liver cancer, will be held on September 18, from 5-7 p.m. at the UH Cancer Center's Sullivan Conference Room. Register to attend in person or online until September 13.
The event will feature experts who will discuss the prevalence of liver cancer in Hawaiʻi, common symptoms and available treatments, including surgery, locoregional therapies, chemotherapy, immunotherapy and radiation. Attendees will also hear about groundbreaking research being conducted at the UH Cancer Center, as well as the inspiring personal journey of a liver cancer survivor.
Featured speakers include:
For more details, view the event flyer or contact Michelle Hashimoto at [email protected].
About the University of Hawaiʻi Cancer Center
The University of Hawaiʻi Cancer Center is dedicated to conquering cancer, inspiring hope, and saving lives in Hawai'i and the Pacific. It strives to do this through research, education, patient care and community outreach, with an emphasis on the diverse and unique ethnic, cultural and environmental characteristics of Hawaiʻi and the Pacific. The UH Cancer Center adds more than $57 million to the Oʻahu economy through scientific research, clinical trials and numerous other activities. It is one of only 72 cancer-research institutions designated by the National Cancer Institute, a mark of rigor and excellence, and the only NCI-designated cancer center in Hawai'i and the Pacific.